11-2130822-G-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_000612.6(IGF2):​c.*2165C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.000089 ( 0 hom., cov: 14)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

IGF2
NM_000612.6 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0770

Publications

17 publications found
Variant links:
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IGF2NM_000612.6 linkc.*2165C>G 3_prime_UTR_variant Exon 4 of 4 ENST00000416167.7 NP_000603.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IGF2ENST00000416167.7 linkc.*2165C>G 3_prime_UTR_variant Exon 4 of 4 1 NM_000612.6 ENSP00000414497.2
IGF2ENST00000381406.8 linkc.*2165C>G 3_prime_UTR_variant Exon 4 of 4 2 ENSP00000370813.4
IGF2ENST00000381395.5 linkc.*2165C>G 3_prime_UTR_variant Exon 4 of 4 2 ENSP00000370802.1

Frequencies

GnomAD3 genomes
AF:
0.0000893
AC:
6
AN:
67214
Hom.:
0
Cov.:
14
show subpopulations
Gnomad AFR
AF:
0.000230
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000549
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000298
Gnomad OTH
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
8248
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
3914
African (AFR)
AF:
0.00
AC:
0
AN:
252
American (AMR)
AF:
0.00
AC:
0
AN:
164
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
484
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3024
South Asian (SAS)
AF:
0.00
AC:
0
AN:
44
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
42
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
3704
Other (OTH)
AF:
0.00
AC:
0
AN:
532
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000892
AC:
6
AN:
67252
Hom.:
0
Cov.:
14
AF XY:
0.0000622
AC XY:
2
AN XY:
32174
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000229
AC:
4
AN:
17430
American (AMR)
AF:
0.00
AC:
0
AN:
5174
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1872
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2638
South Asian (SAS)
AF:
0.000550
AC:
1
AN:
1818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
3354
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
116
European-Non Finnish (NFE)
AF:
0.0000298
AC:
1
AN:
33556
Other (OTH)
AF:
0.00
AC:
0
AN:
886
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000412196), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
1209

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
2.9
DANN
Benign
0.91
PhyloP100
-0.077

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3802971; hg19: chr11-2152052; API